References
- Abraham S, Knapp DW, Cheng L, et al (2006). Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res, 12, 353-60. https://doi.org/10.1158/1078-0432.CCR-05-1505
- Barrett JC (2009). Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc, 2009, pdb ip71.
- Brantley DM, Cheng N, Thompson EJ, et al (2002). Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene, 21, 7011-6. https://doi.org/10.1038/sj.onc.1205679
- Burk U, Schubert J, Wellner U, et al (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep, 9, 582-9. https://doi.org/10.1038/embor.2008.74
- Center MM, Jemal A, Ward E (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-4. https://doi.org/10.1158/1055-9965.EPI-09-0090
- Cui XD, Lee MJ, Yu GR, et al (2010). EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma. Int J Cancer, 126, 940-9.
- Cummins JM, He Y, Leary RJ, et al (2006). The colorectal microRNAome. Proc Natl Acad Sci U S A, 103, 3687-2. https://doi.org/10.1073/pnas.0511155103
- Dobrzanski P, Hunter K, Jones-Bolin S, et al (2004). Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res, 64, 910-9. https://doi.org/10.1158/0008-5472.CAN-3430-2
- Holzman LB, Marks RM, Dixit VM (1990). A novel immediateearly response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol Cell Biol, 10, 5830-8. https://doi.org/10.1128/MCB.10.11.5830
- Huxley RR, Ansary-Moghaddam A, Clifton P, et al (2009). The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer, 125, 171-80. https://doi.org/10.1002/ijc.24343
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-7. https://doi.org/10.1158/1055-9965.EPI-10-0437
- Kaiser S, Park YK, Franklin JL, et al (2007). Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol, 8, R131. https://doi.org/10.1186/gb-2007-8-7-r131
- Landi D, Gemignani F, Pardini B, et al (2012). Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. Cancer, 118, 4670-0. https://doi.org/10.1002/cncr.27435
- Larkin SE, Holmes S, Cree IA, et al (2012). Identification of markers of prostate cancer progression using candidate gene expression. Br J Cancer, 106, 157-5. https://doi.org/10.1038/bjc.2011.490
- Li Y, Nie Y, Cao J, et al (2012). G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer. Mol Carcinog, (in press).
- Lips EH, van Eijk R, de Graaf EJ, et al (2008). Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis. BMC Cancer, 8, 314. https://doi.org/10.1186/1471-2407-8-314
- Nakamura R, Kataoka H, Sato N, et al (2005). EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci, 96, 42-7. https://doi.org/10.1111/j.1349-7006.2005.00007.x
- Nasiri H, Forouzandeh M, Rasaee MJ, et al (2005). Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal, 19, 229-2. https://doi.org/10.1002/jcla.20083
- Nicoloso MS, Sun H, Spizzo R, et al (2010). Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res, 70, 2789-8. https://doi.org/10.1158/0008-5472.CAN-09-3541
- Notterman DA, Alon U, Sierk AJ, et al (2001). Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res, 61, 3124-0.
- Poliakov A, Cotrina M, Wilkinson DG (2004). Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell, 7, 465-0. https://doi.org/10.1016/j.devcel.2004.09.006
- Potla L, Boghaert ER, Armellino D, et al (2002). Reduced expression of EphrinA1 (EFNA1) inhibits three-dimensional growth of HT29 colon carcinoma cells. Cancer Lett, 175, 187-5. https://doi.org/10.1016/S0304-3835(01)00613-9
- Shi ZZ, Zhang YM, Shang L, et al (2012). Genomic profiling of rectal adenoma and carcinoma by array-based comparative genomic hybridization. BMC Med Genomics, 5, 52. https://doi.org/10.1186/1755-8794-5-52
- Yamamoto H, Tei M, Uemura M, et al (2013). Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer. Int J Oncol, 42, 549-5. https://doi.org/10.3892/ijo.2012.1750
- Yang L, Belaguli N, Berger DH (2009). MicroRNA and colorectal cancer. World J Surg, 33, 638-6. https://doi.org/10.1007/s00268-008-9865-5
Cited by
- EphB1 and Ephrin-B, New Potential Biomarkers for Squamous Cell/adenosquamous Carcinomas and Adenocarcinomas of the Gallbladder vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1441
- mRNA–miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation vol.13, pp.10, 2017, https://doi.org/10.1039/C7MB00400A
- Voltage-gated calcium channels: Novel targets for cancer therapy vol.14, pp.2, 2017, https://doi.org/10.3892/ol.2017.6457